These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23832542)

  • 1. Quantitative assessment of the relationship between p21 Ser31Arg polymorphism and cervical cancer.
    Ma Y; Zhang Y; Lin L; Guo X; Wu Y; Wen W; Li F; Liu P
    Tumour Biol; 2013 Dec; 34(6):3887-92. PubMed ID: 23832542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P21 Ser31Arg polymorphism and cervical cancer risk: a meta-analysis.
    Li Y; Liu F; Tan S; Li S
    Int J Gynecol Cancer; 2011 Apr; 21(3):445-51. PubMed ID: 21430453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects.
    Qiu LX; Zhang J; Zhu XD; Zheng CL; Sun S; Wang ZH; Zhao XM; Wang JL; Wang LP; Yu H; Xue K; Hu XC
    Breast Cancer Res Treat; 2010 Nov; 124(2):475-9. PubMed ID: 20349127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.
    Lima G; Santos E; Angelo H; Oliveira M; Heráclio S; Leite F; de Melo C; Crovella S; Maia M; Souza P
    Tumour Biol; 2016 Aug; 37(8):10935-41. PubMed ID: 26886286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between p21 Ser31Arg Polymorphism and Gastrointestinal Tract Tumor Risk: A Meta-analysis.
    Dong Y; Wang X; Ye X; Wang G; Li Y; Wang N; Yang Y; Chen Z; Yang W
    Technol Cancer Res Treat; 2015 Oct; 14(5):627-33. PubMed ID: 24645745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis.
    Ma H; Zhou Z; Wei S; Wei Q
    Chin J Cancer; 2011 Apr; 30(4):254-63. PubMed ID: 21439247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women.
    Jiang P; Liu J; Li W; Zeng X; Tang J
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):671-6. PubMed ID: 20732856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
    Zhang H; Wen X; Lu X; Zhang H
    Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P21 codon 31 polymorphism associated with cancer among white people: evidence from a meta-analysis involving 78,074 subjects.
    Liu F; Li B; Wei Y; Chen X; Ma Y; Yan L; Wen T
    Mutagenesis; 2011 Jul; 26(4):513-21. PubMed ID: 21415438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of the relationship between p21 Ser31Arg polymorphism and lung cancer susceptibility.
    Lin G; Fang F; Yu XJ; Yu L
    Genet Mol Res; 2011 Oct; 10(4):2449-56. PubMed ID: 22009857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between FAS A670G polymorphism and susceptibility to cervical cancer: evidence from a meta-analysis.
    Shen J; Sun NX
    Tumour Biol; 2013 Dec; 34(6):3443-8. PubMed ID: 23900676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis.
    Cacina C; Yaylim-Eraltan I; Arikan S; Saglam EK; Zeybek U; Isbir T
    In Vivo; 2010; 24(2):179-83. PubMed ID: 20363991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians.
    Zhao H; Zhu F; Sun J; Meng X
    Tumour Biol; 2014 Mar; 35(3):2111-6. PubMed ID: 24142528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p21 SNPs and risk of cervical cancer among Chinese women.
    Wang N; Wang S; Zhang Q; Lu Y; Wei H; Li W; Zhang S; Yin D; Ou Y
    BMC Cancer; 2012 Dec; 12():589. PubMed ID: 23231583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis.
    Hu S; Pu D; Xia X; Guo B; Zhang C
    Medicine (Baltimore); 2020 Mar; 99(11):e19433. PubMed ID: 32176070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
    Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
    Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D; Jiang H; Gu Q; Zhang D; Li Z
    Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk.
    Jiang H; Wu D; Ma D; Lin G; Liang J; Jin J
    Tumour Biol; 2013 Dec; 34(6):3417-21. PubMed ID: 23807675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10 polymorphisms and cervical cancer risk: a meta-analysis.
    Ni J; Ye Y; Teng F; Wu Q
    Int J Gynecol Cancer; 2013 Jan; 23(1):126-33. PubMed ID: 23095823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
    Li Y; Liu F; Tan SQ; Wang Y; Li SW
    PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.